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Abstract
Lipopolysaccharide (LPS, a Gram-negative bacterium cell wall component) is a potent macrophage activator that inhibits
macrophage proliferation and stimulates production of nitric oxide (NO) via NO synthase II (NOSII). We investigated
whether NO mediates the LPS-stimulated cell cycle arrest in mouse bone marrow-derived macrophages (BMM). The
addition of the NO donor DETA NONOate (200 WM) inhibited BMM proliferation by approx. 80%. However, despite NO
being an antimitogen, LPS was as potent at inhibiting proliferation in BMM derived from NOSII3/3 mice as from wild-type
mice. Consistent with these findings, LPS-induced cell cycle arrest in normal BMM was not reversed by the addition of the
NOSII inhibitor S-methylisothiourea. Moreover, in both normal and NOSII3/3 BMM, LPS inhibited the expression of
cyclin D1, a protein that is essential for proliferation in many cell types. Despite inhibiting proliferation DETA NONOate
had no effect on cyclin D1 expression. Our data indicate that while both LPS and NO inhibit BMM proliferation, LPS
inhibition of BMM proliferation can occur independently of NOSII induction. ß 2001 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Macrophages are key players in the immune re-
sponse against foreign organisms. Upon encounter-
ing Gram-negative bacteria, macrophages detect
lipopolysaccharide (LPS) in the bacterial cell wall,
resulting in the activation of many signalling path-
ways, which in turn regulate the expression of genes
directing the plethora of macrophage responses to
bacterial challenge [1]. One such response is the pro-
duction of large amounts of the toxic gas nitric oxide
(NO) via the enzyme NO synthase II (iNOS or NO-
SII) [2]. In addition, LPS blocks macrophage prolif-
eration [3,4]. It is possible that LPS-stimulated NO
production and cell cycle arrest are linked, as NO is
known to inhibit proliferation in a wide range of cell
types (e.g. [5^7]). Such a link could be viewed as
advantageous as it would ensure that replicating
macrophage DNA would not be exposed to the mu-
tagenic free radical NO and its derivatives such as
peroxynitrite [8].
The role, if any, of NO in LPS-stimulated cell
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cycle arrest is unde¢ned. Evidence for a link between
LPS-stimulated NO production and cell cycle arrest
includes data from our recent studies examining LPS
responses in macrophages from mice with a null mu-
tation in a chain of the type I IFN receptor (IF-
NAR13/3). In response to LPS, macrophages
from IFNAR13/3 mice were not only resistant to
cell cycle arrest, but were also unable to make NO
[9]. Others have shown that the addition of the NOS
inhibitor N-methyl-L-arginine (L-NMA) increased
proliferation in an LPS-treated macrophage cell line
[10]. In addition, it has been reported that the ability
of urea to reverse the antiproliferative e¡ect of LPS
on a macrophage cell line was linked to its ability to
inhibit NOSII expression [11]. Consistent with these
¢ndings, exogenously added NO is reported to inhib-
it proliferation of a macrophage-like cell line [12].
The above reports appear to support the idea that
NO mediates LPS-stimulated cell cycle arrest. How-
ever, in contrast, others have shown that the NOS
inhibitors L-NAME and L-canavanine had no e¡ect
on LPS-induced cell cycle arrest in a macrophage cell
line, suggesting that NO does not mediate the anti-
mitogenic actions of LPS [13].
While it is di⁄cult to determine the exact reason(s)
for the con£icting conclusions presented in the liter-
ature, there are possible explanations. Other than our
studies [9], all of the above studies employed cell
lines. Cell lines can develop altered characteristics
upon long term culture, and can show abnormal
perturbations in cell cycle machinery [14]. Also, in
the studies summarised above, di¡erent pharmaco-
logical inhibitors of NOS were used, and these agents
were not highly speci¢c for inhibition of NOSII.
The present study investigating the role of NO in
LPS-stimulated cell cycle arrest used approaches that
sought to overcome some of the potential problems
associated with previous studies. Firstly, rather than
a cell line, primary macrophages were used, namely,
mouse bone marrow-derived macrophages (BMM).
Secondly, BMM from NOSII3/3 mice [15] were
used, which to our knowledge is the ¢rst time that
such a ‘genetic’ approach has been applied to this
biological question. Lastly, the NOSII inhibitor S-
methylisothiourea (SMT) was chosen as it is reported
to be highly selective for NOSII and to be far more
potent than L-NMA [16,17].
2. Materials and methods
2.1. Reagents
Reagents were obtained from the following sour-
ces: RPMI medium from ICN-Flow Laboratories
(Sydney, Australia); fetal calf serum (FCS) from
CSL (Parkville, Australia); L-cell-conditioned me-
dium was used as a source of CSF-1, and was pre-
pared as previously described [18]; recombinant hu-
man CSF-1 was a gift from Chiron (USA); LPS was
purchased from Sigma (St. Louis, MO, USA) (cat.
No. L-2630), and was derived from Escherichia coli
serotype 0111:B4; DETA NONOate (DN) was from
Cayman Chemicals (Ann Arbor, MI, USA), and was
prepared and stored as recommend by the manufac-
turer; S-methylisothiourea was purchased from Sig-
ma; tritiated thymidine was from Amersham UK
(cat. No. TRA61).
2.2. Antibodies
Anti-iNOS rabbit polyclonal antibody was from
Transduction Laboratories (Lexington, KY, USA)
(cat. No. 32030). Anticyclin D1 mouse monoclonal
antibody was from Santa Cruz (sc450); HRPO-con-
jugated secondary antibodies were from Silenus
(Hawthorn, Australia).
2.3. Cells
Primary cultures of mouse BMM were generated
as previously described [18,19], and grown in RPMI,
10% FCS, and 30% L-cell-conditioned medium
(source of CSF-1). BMM were rendered quiescent
by incubation for approx. 18 h in CSF-1-depleted
medium. Cell culture incubator conditions were 5%
CO2, 37‡C.
Standard BMM used in this study were derived
from CBA-C57Bl6 or Balb/c mice. NOSII3/3
BMM were derived from NOSII3/3 mice [15], and
the wild-type (‘WT’) or ‘+/+’ BMM were derived
from a matching strain.
In all experiments BMM were examined by light
microscopy at the end of the incubation periods and
there was no indication of cytotoxicity (e.g. non-ad-
herent cells) following incubation with LPS or DN.
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2.4. Nitric oxide assay
BMM in 24-well plates were stimulated in 500 Wl
incubation volumes as described in the text for ap-
prox. 24 h. Cell-conditioned medium was collected
for analysis of nitrites using the Griess reagent as
previously described [20]. Brie£y, 100 Wl of Griess
reagent (equal volumes of 0.1% naphthylethylenedi-
amine (dissolved in water) and 1% sulphanilamide
(dissolved in 5% phosphoric acid)) were added to
100 Wl of cell-conditioned medium, incubated for
5 min at room temperature and absorbance at
550 nm measured using a Labsystems Multiscan
RC microplate reader. A standard curve was con-
structed using a nitrite solution serially diluted in
cell culture medium.
2.5. Western blotting
Quiescent BMM in six-well dishes (approx. 1U106
cells/well) were treated as described in the text and
harvested for Western blotting using standard proce-
dures previously described [4]. Membranes were
probed with primary antibodies (at 100^125 ng/ml),
then appropriate HRPO-conjugated secondary anti-
body and bands detected by chemiluminescence
(ECL, Amersham, UK).
2.6. DNA synthesis assay
BMM in 24-well plates were incubated with the
indicated agents for approx. 24 h in the presence of
0.5 WCi/ml tritiated thymidine. Cells were harvested
by gently tipping o¡ the medium, adding 0.2 M
NaOH (0.5 ml) and aspirating onto glass ¢bre ¢lters
using an Inotech cell harvester. Filters were dried
and radioactivity on ¢lter discs detected by scintilla-
tion counting (Packard TopCount).
3. Results
To determine whether NO inhibited mouse BMM
proliferation, quiescent BMM were stimulated to
proliferate with CSF-1 (5000 U/ml), in the presence
or absence of the NO donor DN for approx. 24 h.
The conditioned medium from the cells was collected
for determination of nitrite concentration (a stable
end product of NO breakdown), and the cells were
assayed for DNA synthesis. While 10 WM DN had
no e¡ect on CSF-1-stimulated DNA synthesis, 200
WM DN inhibited DNA synthesis by 78% (Table
1). Unstimulated or CSF-1-stimulated BMM did
not produce detectable levels of nitrite, while the
addition of 10 WM DN and 200 WM DN resulted
in the detection of 6 WM nitrite and 89 WM nitrite,
respectively.
Having established that BMM were sensitive to
NO-induced cell cycle arrest, we next examined the
e¡ect of the NOSII inhibitor SMT [16] on the ability
of LPS to inhibit proliferation in BMM. Quiescent
BMM were stimulated to proliferate with CSF-1
(5000 U/ml), in the presence or absence of the indi-
cated concentrations of LPS and SMT for approx.
24 h, after which the medium from the cells was
collected for determination of nitrite concentration,
and the cells were assessed for DNA synthesis. LPS
at 0.1 ng/ml inhibited proliferation by about 50%,
while 1^100 ng/ml completely inhibited proliferation
(Fig. 1). The addition of the NOSII inhibitor SMT
(50 WM) had no e¡ect on the ability of LPS to inhibit
proliferation (Fig. 1). As expected, SMT reduced the
levels of nitrite detected in medium from LPS-stimu-
lated BMM (Table 2). These data suggest that NO
does not mediate LPS-stimulated cell cycle arrest.
Experiments were performed using BMM derived
from NOSII3/3 mice [15] in order to con¢rm the
data generated with the pharmacological agent SMT.
Table 1
E¡ect of DN on proliferation and medium nitrite concentration in normal BMM
Treatment DNA synthesis (dpm) Nitrite (WM)
Unstimulated 1 853 þ 423 0 þ 2
CSF-1 29 250 þ 2 211 0 þ 2
CSF-1+10 WM DN 30 752 þ 2 243 6 þ 1
CSF-1+200 WM DN 6 502 þ 1 701 89 þ 8
Cells were incubated with the indicated agents and DNA synthesis and medium nitrite concentration were measured after 24 h. Data
are representative of three such experiments and are mean þ S.D. of quadruplicate determinations.
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Quiescent BMM were stimulated to proliferate with
CSF-1 (5000 U/ml), in the presence or absence of
LPS or DN, as indicated. After 24 h, the medium
from the cells was collected for determination of ni-
trite concentration, and the cells were assessed for
DNA synthesis. LPS (1^100 ng/ml) inhibited prolif-
eration in both +/+ and NOSII3/3 BMM (Table 3).
These data con¢rm that NO does not mediate the
LPS-stimulated cell cycle arrest in BMM. The DN
data in Table 3 also show that both +/+ and NO-
SII3/3 BMM are sensitive to NO-induced cell cycle
arrest.
Cyclin D1 is a protein critical for G1 progression
in many cell types [21]. To investigate why LPS was
still able to block proliferation in NOSII3/3 BMM
the e¡ect of LPS on cyclin D1 expression was deter-
mined. Quiescent BMM were stimulated with the in-
dicated agents for approx. 8 h and cyclin D1 levels
measured in lysates by Western blotting. The data in
Fig. 2 show both +/+ and NOSII3/3 BMM express
cyclin D1 in response to 5000 U/ml CSF-1, and this
expression is inhibited by 100 ng/ml LPS. In con-
trast, 100 WM DN was found to have no e¡ect on
CSF-1-stimulated cyclin D1 expression, even though
it inhibited proliferation by about 50% (see Table 3).
Other experiments using 200 WM DN, which led to
approx. 80% inhibition of DNA synthesis (see Table
1), also showed there was no e¡ect on CSF-1-stimu-
lated cyclin D1 protein expression (data not shown).
4. Discussion
LPS, a potent macrophage activator, inhibits mac-
rophage proliferation and stimulates production of
NO. There are con£icting reports regarding the role
of NO in LPS-stimulated cell cycle arrest. While
some reports indicate LPS inhibits cell proliferation
Table 2
The e¡ect of LPS and SMT on medium nitrite concentration
(WM) in normal BMM
Treatment plus SMT
Unstimulated 0 þ 2 0 þ 2
CSF-1 0 þ 2 0 þ 2
CSF-1+0.1 ng/ml LPS 0 þ 5 0 þ 2
CSF-1+1 ng/ml LPS 23 þ 3 3 þ 0
CSF-1+10 ng/ml LPS 35 þ 3 11 þ 1
CSF-1+100 ng/ml LPS 36 þ 4 17 þ 1
Cells were incubated with the indicated agents and medium ni-
trite concentration was measured after 24 h. Data are represen-
tative of three such experiments and are mean þ S.D. of quad-
ruplicate determinations.
Fig. 1. The e¡ect of SMT on LPS-stimulated cell cycle arrest. Quiescent BMM were left unstimulated, or stimulated with CSF-1
(5000 U/ml) and LPS (0.1^100 ng/ml) in the absence (black bars) or presence (grey bars) of SMT (50 WM), for approx. 24 h. Data
show mean þ S.D. for quadruplicate determinations, and are representative of four similar experiments.
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by increasing NO production [9^11], others have
shown this is not the case [13]. The aim of the cur-
rent study was to further examine the role of NO in
LPS-induced cell cycle arrest using both pharmaco-
logical and genetic approaches. The present work
indicates that LPS inhibition of BMM proliferation
is independent of NO production.
Although NO inhibits proliferation of a number of
cell types (e.g. [5^7]) there are surprisingly few stud-
ies which have reported on the e¡ect of NO donors
on macrophage proliferation. One such study showed
that NO donors inhibited proliferation of the macro-
phage-like Mm1 cells, arresting them in the G2/M
phase of the cell cycle [12]. In the present study we
used ‘quiescent’ BMM, which are synchronised in
G0/early G1 due to 18 h growth factor deprivation
[4]. Upon stimulation with CSF-1, these cells re-enter
the cell cycle and take around 24 h to complete a
round of replication [4]. We found that addition of
the NO donor DN inhibited the cells from entering
S phase, indicating a G1 phase arrest.
Having established that BMM were sensitive to
NO-induced cell cycle arrest, we examined the role
NO in LPS-stimulated cell cycle arrest. We found
that co-addition of the NOSII inhibitor SMT signi¢-
cantly reduced LPS-stimulated NO production, as
expected. However, SMT had no e¡ect on LPS-
stimulated cell cycle arrest. This was apparent even
when the concentration of LPS used was submaximal
in terms of inhibition of proliferation (0.1 ng/ml LPS,
Fig. 1). Furthermore, we found that NOSII3/3
BMM were as sensitive to LPS-stimulated cell cycle
arrest as were normal BMM. These data indicate
LPS inhibits BMM proliferation via NO-independent
mechanisms.
It is noteworthy that 1 ng/ml LPS was still po-
tently antimitogenic in the presence of SMT, even
though the SMT reduced nitrite levels from 23 WM
to 3 WM (Fig. 1 and Table 2). Therefore, LPS that
generated 3 WM nitrite was more antimitogenic than
10 WM DN that generated 6 WM nitrite (Table 1).
Thus, the NO level in response to an antimitogenic
concentration of LPS remained below the threshold
Fig. 2. The e¡ect of LPS and DN on cyclin D1 expression in
BMM. Quiescent BMM (0) from either wild-type (+/+) or NO-
SII3/3 mice were stimulated with CSF-1 (5000 U/ml), LPS
(100 ng/ml) or DN (100 WM), as indicated. Cells were harvested
after 8 h for Western blotting and detection of cyclin D1 (ap-
prox. 36 kDa). These data are representative of three such ex-
periments.
Table 3
E¡ect of LPS and DN on proliferation and nitrite production in +/+ and NOSII3/3 BMM
Genotype LPS (ng/ml) DN (WM) DNA synthesis (dpm) Nitrite (WM)
+/+ Unstimulated ^ ^ 530 þ 101 4.0 þ 0.1
+/+ CSF-1 ^ ^ 77 534 þ 7 030 4.1 þ 0.1
+/+ CSF-1+ 1 ^ 436 þ 120 5.7 þ 0.7
+/+ CSF-1+ 10 ^ 579 þ 231 16.1 þ 4.0
+/+ CSF-1+ 100 ^ 330 þ 91 18.7 þ 3.1
+/+ CSF-1+ ^ 10 72 020 þ 11 091 8.1 þ 0.1
+/+ CSF-1+ ^ 100 35 101 þ 4 002 39.5 þ 3.9
3/3 Unstimulated ^ ^ 679 þ 222 4.4 þ 0
3/3 CSF-1 ^ ^ 77 010 þ 7 211 4.0 þ 0
3/3 CSF-1+ 1 ^ 551 þ 210 3.8 þ 0.1
3/3 CSF-1+ 10 ^ 811 þ 501 3.8 þ 0.2
3/3 CSF-1+ 100 ^ 532 þ 280 4.1 þ 0.3
3/3 CSF-1+ ^ 10 77 302 þ 7 101 9.1 þ 0.4
3/3 CSF-1+ ^ 100 34 020 þ 7 201 39.1 þ 8.2
Cells were incubated with the indicated agents and DNA synthesis and medium nitrite concentration were measured after 24 h. Data
are representative of three experiments using two di¡erent primary BMM preparations. Data are mean þ S.D. of triplicate determina-
tions.
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for NO-induced G1 arrest, further indicating that
NO does not play a role in LPS-stimulated cell cycle
arrest.
D-type cyclins are growth factor sensors that are
essential and rate limiting for G1 progression in nor-
mal mammalian cells [21]. We have previously shown
that following addition of CSF-1, cyclin D1 is the
major D-type cyclin expressed in BMM [22]. We
have also shown that LPS potently inhibits cyclin
D1 expression in BMM [4,23]. In the present study
we show that LPS also inhibits cyclin D1 expression
in NOSII3/3 BMM. This observation is likely to
explain the NO-independent G1 arrest by LPS in
NOSII3/3 BMM. Furthermore, DN did not inhibit
CSF-1-stimulated cyclin D1 protein expression in
BMM, indicating that NO inhibits BMM prolifera-
tion via mechanisms other than repression of D-type
cyclin expression. This observation further separates
antiproliferative mechanisms of NO and LPS, and is
consistent with LPS inhibiting BMM proliferation
through NO-independent pathways.
The present data appear to be the ¢rst reporting
on the e¡ect of NO on expression of a cell cycle
protein in macrophages. They are similar to data
generated using vascular smooth muscle cells which
showed NO had no e¡ect on cyclin D1 expression in
[24], but that NO was linked to repression of cyclins
A and E expression [24,25], inhibition of cyclin-de-
pendent kinase 2 activity [24,26] and upregulation of
expression of the cyclin-dependent kinase inhibitor
p21 [24,27].
The present study indicates that LPS-induced cell
cycle arrest is independent of NO production. This
di¡ers from the conclusions drawn by others (see
Section 1). We are unsure as to the reasons for the
apparently con£icting ¢ndings. The studies described
here used primary cells, and to our knowledge are
the ¢rst to use macrophages derived from NOSII3/
3 mice to explore this question. The design of our
studies is therefore in contrast to others which used
the macrophage-like cell line RAW264.7. It may be
that this cell line has, or develops over time, altered
LPS/NO responses compared to primary cells. Given
that both NO and LPS alter expression of cell cycle
proteins, it is pertinent to note that cell lines can
show altered expression of cell cycle proteins [14],
as can subcultured primary cells [28]. Thus, we con-
tend the current ¢ndings are more likely to re£ect the
behaviour of macrophages in vivo.
The present work contributes to our understand-
ing of mechanisms underlying macrophage-mediated
host defence. Given both LPS and NO inhibit mac-
rophage proliferation, it seemed reasonable to expect
LPS-stimulated NO production and cell cycle arrest
to be linked, especially since NO is a genotoxic agent
and such a link would avoid exposing replicating
DNA to NO. However, our data indicate this is
not the case, and suggest that LPS invokes other
mechanisms in order to inhibit proliferation. How-
ever, the present study may point toward an impor-
tant backup mechanism in that if the primary NO-
independent antiproliferative mechanisms of LPS
somehow become disabled, high levels of NO will
ultimately inhibit proliferation and prevent exposure
of replicating DNA. That LPS and NO both block
proliferation is probably also important in ensuring
that the challenged macrophage directs its energy
towards immediately producing compounds to ¢ght
invading bacteria, rather than towards cell division.
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